Cellect Biomed Ltd. announced additions to its management and professional teams in support of its preparations for the commencement of human clinical trials and its planned dual-listing on a U.S. stock exchange. Ronen Twito, CPA has joined the company as its Deputy CEO and CFO. Most recently, Mr. Twito served as VP Finance at BioBlast Pharma.

The company also appointed Dr. Amotz Nechushtan as its VP Business Development. Dr. Nechushtan most recent position was CEO of Iluten. In his new role with Cellect, he will be responsible for the company's product platform and for expanding the collaboration with its American partner, Entegris.